In the current study, CD44 or CD147-KD xenografts treated with DTX, showed significant targeted areas with tumor islands and obviously reduced MVD, suggesting that DTX may have a similar anti-angiogenic function as seen in the EOC model [28]. This evidence concerns the gene BSG and neoplasm.